Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Alzheimer's Disease and Related Disorders Annual 5

Informa Healthcare, Sep 2005, Pages: 224


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

A progress report on the cutting-edge research into Alzheimer’s Disease and other forms of dementia, this important volume has particular emphasis on topics that are applicable to clinical practice.
In this latest instalment, Serge Gauthier, Philip Scheltens and Jeffrey Cummings cover some of the emerging therapies for Alzheimer’s Disease, including:
* statins
* GAG minetics
* immunotherapy
* the use of hormonal therapy and atypical anti-psychotic agents in the treatment of other related dementias.
Also summarizing current understanding of the pathophysiology of mild cognitive impairment, as well as research into tau pathologies, this is a key addition to literature in the area.




Customers who bought this item also bought

Alzheimer's Disease and Related Disorders

Alzheimer’s Disease – The Evaluation & Management of Dementia 2012

Mild Cognitive Impairment and Early Alzheimer's Disease: Detection and Diagnosis

Nitric Oxide - Therapeutics, Markets and Companies

Expanding a Brand: Statins and PPAR-Gamma Agonists to Treat Neurological Disease

Principles and Practice of Geriatric Psychiatry, 3rd Edition

Clinical Guide to the Diagnosis and Treatment of Mental Disorders, 2nd Edition

Prescribing Influences: Alzheimer's Disease - Alleviating symptoms remains the goal for prescribers

Therapeutic Strategies in Schizophrenia

Pipeline and Commercial Insight: Alzheimer's Disease - Market cautiously awaits the first generation of disease-modifying therapies



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds